Log In
BCIQ
Print this Print this
 

Lysteda, tranexamic acid (XP12B)

  Manage Alerts
Collapse Summary General Information
Company Ferring Pharmaceuticals A/S
DescriptionModified-release formulation of tranexamic acid
Molecular Target Plasmin
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBleeding
Indication DetailsTreat menorrhagia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/17/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today